Chat with us, powered by LiveChat

How Research Sites Can Win with Decentralized Trials – Part 3 – Remote Consenting

Remote consent is one of the main technological and operational advantages that supports direct-to-patient recruitment. In Part 3 of our 7-part webinar, join the conversation around the willingness to adopt remote consenting services, as well as the challenges of multinational clinical trials covering different languages.

Topics covered over the course of 7 sessions include:

Panelists

Raymond Nomizu, CEO & co-founder, Clinical Research IO (CRIO) – a site-centered eSource and CTMS solution

Edye T. Edens, Senior Research Compliance Consultant, First Class Solutions

Daniel Perez, COO, MACRO Trials – a Site Optimization Organization (SOO)

Maya Zlatanova, CEO, TrialHub

In Part 4 –  QA/QC Remote Monitoring, our panel discusses the risks and benefits of decentralized trials.

 

Learn More About CRIO

BOOK A 20-MINUTE DEMO TO LEARN ABOUT OUR PRODUCT